A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Clinical trial NCT05440708 · RECRUITING
Trial details
- NCT number
- NCT05440708
- Sponsor
- Tvardi Therapeutics, Incorporated
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2027-02-01
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.